Evidence map›Paper›PMID 32236313›Full record

ReviewArchives of endocrinology and metabolism2020

Cholestatic syndrome as initial manifestation of pancreatic metastasis of papillary thyroid carcinoma: case report and review.

Mariana Yoshii Tramontin, Paulo Antônio Silvestre de Faria, Cristina Moreira do Nascimento, Cibele de Aquino Barbosa, Maria de Fátima Rei Pereira Barros, Aniela Rodrigues Gomes de Barros, Rafaela Cardoso de Carvalho, Antônio Kneipp Pitta de Castro Neto, Fernanda Accioly de Andrade, Rossana Corbo and 2 more

Open access · diamondAbstract readCase ReportsReview
In one paragraph

Review in Archives of endocrinology and metabolism, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Mariana Yoshii TramontinUnidade de Endocrinologia Oncológica, Instituto Nacional de Câncer José Alencar Gomes da Silva, Rio de Janeiro, RJ, Brasil.
Paulo Antônio Silvestre de FariaDivisão de Patologia, Instituto Nacional de Câncer José Alencar Gomes da Silva, Rio de Janeiro, RJ, Brasil.
Cristina Moreira do NascimentoDivisão de Patologia, Instituto Nacional de Câncer José Alencar Gomes da Silva, Rio de Janeiro, RJ, Brasil.
Cibele de Aquino BarbosaSeção de Cirurgia Abdominopélvica, Instituto Nacional de Câncer José Alencar Gomes da Silva, Rio de Janeiro, RJ, Brasil.
Maria de Fátima Rei Pereira BarrosServiço de Cirurgia Geral e Oncológica, Hospital Central da Polícia Militar, Rio de Janeiro, RJ, Brasil.
Aniela Rodrigues Gomes de BarrosServiço de Cirurgia Geral e Oncológica, Hospital Central da Polícia Militar, Rio de Janeiro, RJ, Brasil.
Rafaela Cardoso de CarvalhoServiço de Cirurgia Geral e Oncológica, Hospital Central da Polícia Militar, Rio de Janeiro, RJ, Brasil.
Antônio Kneipp Pitta de Castro NetoServiço de Cirurgia Geral e Oncológica, Hospital Central da Polícia Militar, Rio de Janeiro, RJ, Brasil.
Fernanda Accioly de AndradeUnidade de Endocrinologia Oncológica, Instituto Nacional de Câncer José Alencar Gomes da Silva, Rio de Janeiro, RJ, Brasil.
Rossana CorboUnidade de Endocrinologia Oncológica, Instituto Nacional de Câncer José Alencar Gomes da Silva, Rio de Janeiro, RJ, Brasil.
Fernanda VaismanUnidade de Endocrinologia Oncológica, Instituto Nacional de Câncer José Alencar Gomes da Silva, Rio de Janeiro, RJ, Brasil.
Daniel BulzicoUnidade de Endocrinologia Oncológica, Instituto Nacional de Câncer José Alencar Gomes da Silva, Rio de Janeiro, RJ, Brasil.
Instituto Nacional de Câncer - INCA · BRHospital Central da Polícia Militar · BRUniversidade Federal do Rio de Janeiro · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Most papillary thyroid carcinomas (PTC) harbor excellent prognosis. Although rare, distant metastases normally occur in lungs and/or bones. Here we describe a rare case of pancreatic metastasis presenting with rapid onset cholestatic syndrome. A literature review was also performed. A 73-year-old man with a high risk PTC was submitted to total thyroidectomy (TT) followed by radioiodine therapy. After initial therapy, he persisted with progressive rising serum thyroglobulin levels but with no evidence of structural disease. Recently, the patient presented with a rapid onset and progressive cholestatic syndrome. A 4 cm lesion in pancreas was identified, with echoendoscopy fine-needle aspiration biopsy (FNAB) confirming a pancreatic metastasis from PTC. The patient was submitted to a successful pancreaticoduodenectomy. Pancreatic metastases of PTC are rare and few long-term follow-up data are available to guide management. Fourteen cases were former reported, mean age was 65.7 years-old with mean time between PTC and pancreatic metastasis diagnosis of 7.9 years. Nine of them had another distant metastasis, nine were diagnosed by FNAB and just two received sorafenib.

Indexed as

AgedBiopsy, Fine-NeedleCholestasisHumansMalePancreatic NeoplasmsSyndromeThyroid Cancer, PapillaryThyroidectomyThyroid Neoplasms

Identifiers

PMID32236313
PMCPMC10118944
OpenAlexW3014219733

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.